Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.
Clinical trial NCT04368273 · UNKNOWN
Trial details
- NCT number
- NCT04368273
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2021-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.